| Notice of Intent to Publish a Funding Opportunity Announcement for Human Virome Project: Developing novel and innovative tools to interrogate and annotate the human virome |
NOT-RM-23-014 (U01 Clinical Trial Not Allowed) |
U01 |
Clinical Trial Not Allowed |
07/31/2024 |
Sharon Ross, Ph.D., M.P.H. |
| Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterize the Human Virome in Longitudinal, Diverse Cohorts Across the Lifespan |
NOT-RM-23-017 (U54 Clinical Trial Not Allowed) |
U54 |
Clinical Trial Not Allowed |
07/31/2024 |
Sharon Ross, Ph.D., M.P.H. |
| Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Characterization of functional interactions between viruses and human and microbial hosts |
NOT-RM-23-015 (U01 Clinical Trial Not Allowed) |
U01 |
Clinical Trial Not Allowed |
07/31/2024 |
Sharon Ross, Ph.D., M.P.H. |
| Notice of Intent to Publish a Funding Opportunity for the NIH Common Fund Human Virome Program: Consortium Organization and Data Collaboration Center (CODCC) for the Human Virome Project (HVP) |
NOT-RM-23-016 (U24 Clinical Trial Not Allowed) |
U24 |
Clinical Trial Not Allowed |
07/31/2024 |
Sharon Ross, Ph.D., M.P.H. |
| Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk |
NOT-CA-23-089 |
|
|
09/08/2024 |
Edward Sauter, M.D., Ph.D. |
| Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention |
NOT-CA-21-121 |
|
|
09/08/2024 |
Sharon Ross, Ph.D., M.P.H. |
| Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer |
PAR-22-061 (R01 Clinical Trial Not Allowed) |
R01 |
Clinical Trial Not Allowed |
01/08/2025 |
Young Kim, Ph.D. |
| Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) |
NOT-OD-22-202 |
|
Clinical Trial Not Allowed |
04/16/2025 |
Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D. |
| NCI Clinical and Translational Exploratory/Developmental Studies |
PAR-22-216 (R21 Clinical Trial Optional) |
R21 |
Clinical Trial Optional |
07/02/2025 |
Marjorie Perloff, M.D. |
| Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases |
NOT-DA-22-048 |
|
|
01/08/2026 |
Sharon Ross, Ph.D., M.P.H. |